Literature DB >> 14626512

Distribution of the HLA class I allele in chronic hepatitis C and its association with serum ALT level in chronic hepatitis C.

Yasuteru Kondo1, Koju Kobayashi, Tomoo Kobayashi, Masaaki Shiina, Yoshiyuki Ueno, Takaomi Satoh, Tooru Shimosegawa.   

Abstract

An essential process for resolution of viral infections is the efficient recognition and elimination of intracellular virus. Recognition of viral antigens in the form of short peptides associated with HLA class I molecule is a major task of CD8+ cytotoxic T lymphocytes. In this study, we have evaluated the frequency of the HLA class I alleles in patients with chronic hepatitis C. HLA-B51, -B52, -B55, -B56, -B61, B70, -Cw1, -Cw3, and -Cw4 are less frequent in patients with chronic hepatitis C than in Japanese individuals. The frequency of HLA-A2 is slightly lower in the patients but tends to be higher in patients with normal alanine aminotransferase (ALT) level than in those with elevated ALT level (p = 0.07). Other HLA alleles are not significantly different between two groups. Comparison of HLA homozygosity at HLA-A and -B or -C or at two or three loci did not show a significant association with levels of serum ALT or with the clinical outcome of interferon therapy in patients with hepatitis C. These results suggest a possibility that the alterations of host response, which depends on genetic background, influence disease activities of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14626512     DOI: 10.1620/tjem.201.109

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  7 in total

1.  Interferon-gamma is produced by CD8 T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus loss.

Authors:  K Kobayashi; M Ishii; M Shiina; Y Ueno; Y Kondo; A Kanno; Y Miyazaki; T Yamamoto; T Kobayashi; H Niitsuma; Y Kikumoto; H Takizawa; T Shimosegawa
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

2.  The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.

Authors:  Mark H Kuniholm; Xiaojiang Gao; Xiaonan Xue; Andrea Kovacs; Darlene Marti; Chloe L Thio; Marion G Peters; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

3.  Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients.

Authors:  Masaaki Shiina; Koju Kobayashi; Tomoo Kobayashi; Yasuteru Kondo; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

Review 4.  Host genetic factors and antiviral immune responses to hepatitis C virus.

Authors:  Chloe L Thio
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

Review 5.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

6.  Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection.

Authors:  S L Rhodes; H Erlich; K A Im; J Wang; J Li; T Bugawan; L Jeffers; X Tong; X Su; H R Rosen; L J Yee; T J Liang; H Yang
Journal:  Genes Immun       Date:  2008-04-17       Impact factor: 2.676

7.  Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT.

Authors:  Yasuteru Kondo; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Hepat Res Treat       Date:  2011-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.